MEDBOX | Toolbox Immunization Guidelines

NEW

World Health Organization WHO (2022) C_WHO

1 March 2021 The diagram supports health workers by outlining key steps and messages to communicate during a COVID-19 vaccination session.

Tags: Health Workers, Vaccination, COVID-19, planning and monitoring, communication,

Source: https://www.who.int/docs/default-source/

NEW

World Health Organization WHO (2021) C_WHO

Tags: Vaccination, COVID-19, vaccine doses,

Source: https://www.who.int/docs/default-source/

Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1

Epidemiologisches Bulletin 16 | 2021 22. April 2021 (online vorab). Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder einem der beiden zugelassenen Vektor-basierten Impfstoffe (COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Janssen). Wie im Epidemiologischen Bulletin 16/2021 ausgeführt, werden die Impfstoffe hinsichtlich des Individualschutzes und der Bekämpfung der Pandemie als gleich geeignet beurteilt. Die beiden mRNA-Impfstoffe und die COVID-19 Vaccine Janssen können in allen Alters- und Indikationsgruppen eingesetzt werden, für die sie zugelassen sind. Eine begonnene Impfserie muss gegenwärtig mit demselben Produkt abgeschlossen werden; eine Ausnahme gilt bei der Impfung von Personen < 60 Jahren, die bereits eine erste Dosis der COVID-19 Vaccine AstraZeneca erhalten haben. Bis entsprechende Daten vorliegen, empfiehlt die STIKO, bei diesen Personen anstelle der zweiten AstraZeneca-Impfstoffdosis eine Dosis eines mRNA-Impfstoffs 12 Wochen nach der Erstimpfung zu verabreichen

Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung,

Source: https://www.rki.de/DE/Content/Infekt/Epi

Comprehensive COVID-19 Slideset: Vaccines and Variants

Clinical Care Options (2021) CC

Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants

Tags: COVID-19, variant, mutation, virus variants, Vaccines, SARS-CoV-2,

Source: https://www.clinicaloptions.com/infectio

Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

World Health Organization WHO (2021) C_WHO

COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive

Tags: pregnant women, Pregnancy, Breastfeeding, COVID-19, Surveillance, safety, Vaccination,

Source: https://cdn.who.int/media/docs/default-s

COVID-19 vaccines and HIV (Arabic Version)

UNAIDS (2021) C_WHO

12 January 2021 The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.

Tags: vaccine, COVID-19, HIV,

Source: https://www.unaids.org/sites/default/fil

A guide to vaccinations for COVID-19

British Society for Immunology (2021) C1

The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK. This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will be updated as it becomes available

Tags: Immunization, Vaccination, guide, COVID-19, SARS-CoV-2, acceptance, hesitancy, cmmunication,

Source: https://www.immunology.org/sites/default

STIKO@rki - die neu gestaltete Impf-App für ÄrztInnen und Gesundheitsfachpersonal

Robert-Koch-Institut RKI (2021) CC

Die STIKO@rki-App wurde für die impfende Ärzteschaft und Fachpersonal im Gesundheitswesen entwickelt, um sie bei Fragen zum Impfen im Praxisalltag zu unterstützen. Mit wenigen Klicks bekommen NutzerInnen die für die Beratung der einzelnen PatientInnen relevanten Informationen. Abrufbar in der App sind auch die Fachinformationen aller Impfstoffe, Antworten auf häufig gestellte Fragen zu Impfungen sowie die RKI-Ratgeber zu impfpräventablen Erkrankungen

Tags: impfempfehlungen, Schutzimpfung, Imfpungen, App,

Source: https://www.rki.de/DE/Content/Kommission

World Health Organization WHO (2021) C_WHO

1 March 2021 The COVID-19 vaccine checklist is for frontline health workers planning a COVID-19 vaccination session. This checklist can help them to prepare and complete a COVID-19 vaccination session at a fixed post or outreach session

Tags: vaccine, COVID-19, vaccination, planning,

Source: https://www.who.int/docs/default-source/

World Health Organization WHO (2021) C_WHO

The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders

Tags: Vaccination, COVID-19, SARS-CoV-2, Strategy, Logistics, Supply, safety, Training, Human resources, hesitancy, demand, acceptance, training, Standards,

Source: https://www.who.int/tools/covid-19-vacci

	Health worker communication for COVID-19 vaccination flow diagram NEW World Health Organization WHO (2022) C_WHO View PDF(8) Download (7) Add to my MEDBOX 1 March 2021 The diagram supports health workers by outlining key steps and messages to communicate during a COVID-19 vaccination session. Tags: Health Workers, Vaccination, COVID-19, planning and monitoring, communication, Source: https://www.who.int/docs/default-source/
	Why are there extra doses of vaccine in the vaccine vial? NEW World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX Tags: Vaccination, COVID-19, vaccine doses, Source: https://www.who.int/docs/default-source/
	Beschluss der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung Vygen-Bonnet S, Koch J, Bogdan C, et al. (2021) C1 View PDF(8) Download (7) Add to my MEDBOX Epidemiologisches Bulletin 16 \| 2021 22. April 2021 (online vorab). Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder einem der beiden zugelassenen Vektor-basierten Impfstoffe (COVID-19 Vaccine AstraZeneca, COVID-19 Vaccine Janssen). Wie im Epidemiologischen Bulletin 16/2021 ausgeführt, werden die Impfstoffe hinsichtlich des Individualschutzes und der Bekämpfung der Pandemie als gleich geeignet beurteilt. Die beiden mRNA-Impfstoffe und die COVID-19 Vaccine Janssen können in allen Alters- und Indikationsgruppen eingesetzt werden, für die sie zugelassen sind. Eine begonnene Impfserie muss gegenwärtig mit demselben Produkt abgeschlossen werden; eine Ausnahme gilt bei der Impfung von Personen < 60 Jahren, die bereits eine erste Dosis der COVID-19 Vaccine AstraZeneca erhalten haben. Bis entsprechende Daten vorliegen, empfiehlt die STIKO, bei diesen Personen anstelle der zweiten AstraZeneca-Impfstoffdosis eine Dosis eines mRNA-Impfstoffs 12 Wochen nach der Erstimpfung zu verabreichen Tags: Impfungen, COVID-19, Strategie, Verteilung, Ethik, Risikogruppen, Priorisierung, Deutschland, mRNA, vector-basierter Impfstoff, Astra Zeneca, Moderna, pfizer, Risiko, Sinusvenenthrombosen, Zweitimpfung, Source: https://www.rki.de/DE/Content/Infekt/Epi
	Comprehensive COVID-19 Slideset: Vaccines and Variants Clinical Care Options (2021) CC Open external link (9) Add to my MEDBOX Slideset updated regularly to include the latest data and guidance on COVID-19 vaccines, including implications of emerging SARS-CoV-2 variants Tags: COVID-19, variant, mutation, virus variants, Vaccines, SARS-CoV-2, Source: https://www.clinicaloptions.com/infectio
	Safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX COVID-19 Vaccines: 1 Safety Surveillance 2 Manual While there is no indication that pregnant women have an increased susceptibility to infection with SARS-CoV-2, there is evidence that pregnancy may increase the risk of severe illness and mortality from COVID-19 disease in comparison with non-pregnant women of reproductive age. As seen with non-pregnant women, a high proportion of pregnant women have asymptomatic SARS-CoV-2 infection and severe disease is associated with recognized medical (e.g., high body-mass index (BMI), diabetes, pre-existing pulmonary or cardiac conditions) and social (e.g., social deprivation, ethnicity) risk factors. Pregnant women with symptomatic COVID-19 appear to have an increased risk of intensive care unit admission, mechanical ventilation and death in comparison with non-pregnant women of reproductive age, although the absolute risks remain low. COVID-19 may increase the risk of preterm birth, compared with pregnant women without COVID-19, although the evidence is inconclusive Tags: pregnant women, Pregnancy, Breastfeeding, COVID-19, Surveillance, safety, Vaccination, Source: https://cdn.who.int/media/docs/default-s
	COVID-19 vaccines and HIV (Arabic Version) UNAIDS (2021) C_WHO View PDF(1) Download (0) Add to my MEDBOX 12 January 2021 The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV. Tags: vaccine, COVID-19, HIV, Source: https://www.unaids.org/sites/default/fil
	A guide to vaccinations for COVID-19 British Society for Immunology (2021) C1 View PDF(2) Download (1) Add to my MEDBOX The guide explains how vaccines work and answers your common questions as well as providing up-to-date information on the current approved COVID-19 vaccinations in the UK. This guide was written in January 2021 and updated in March 2021 and is accurate at the time of publishing. Information will be updated as it becomes available Tags: Immunization, Vaccination, guide, COVID-19, SARS-CoV-2, acceptance, hesitancy, cmmunication, Source: https://www.immunology.org/sites/default
	STIKO@rki - die neu gestaltete Impf-App für ÄrztInnen und Gesundheitsfachpersonal Robert-Koch-Institut RKI (2021) CC Open external link (23) Add to my MEDBOX Die STIKO@rki-App wurde für die impfende Ärzteschaft und Fachpersonal im Gesundheitswesen entwickelt, um sie bei Fragen zum Impfen im Praxisalltag zu unterstützen. Mit wenigen Klicks bekommen NutzerInnen die für die Beratung der einzelnen PatientInnen relevanten Informationen. Abrufbar in der App sind auch die Fachinformationen aller Impfstoffe, Antworten auf häufig gestellte Fragen zu Impfungen sowie die RKI-Ratgeber zu impfpräventablen Erkrankungen Tags: impfempfehlungen, Schutzimpfung, Imfpungen, App, Source: https://www.rki.de/DE/Content/Kommission
	COVID-19 vaccine checklist World Health Organization WHO (2021) C_WHO View PDF(0) Download (0) Add to my MEDBOX 1 March 2021 The COVID-19 vaccine checklist is for frontline health workers planning a COVID-19 vaccination session. This checklist can help them to prepare and complete a COVID-19 vaccination session at a fixed post or outreach session Tags: vaccine, COVID-19, vaccination, planning, Source: https://www.who.int/docs/default-source/
	COVID-19 vaccine introduction toolkit World Health Organization WHO (2021) C_WHO Open external link (23) Add to my MEDBOX The COVID-19 vaccine introduction toolbox equips all countries to prepare for and implement COVID-19 vaccination by providing guidance, tools, and training. This toolbox is intended to support Ministries of Health, health workers, partner organizations, and other stakeholders Tags: Vaccination, COVID-19, SARS-CoV-2, Strategy, Logistics, Supply, safety, Training, Human resources, hesitancy, demand, acceptance, training, Standards, Source: https://www.who.int/tools/covid-19-vacci

About MEDBOX

MEDBOX Video Series